SecSonar.com

Johnson & Johnson (JNJ)

Johnson & Johnson at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Johnson & Johnson (JNJ) is a Drug Manufacturers - General company based in US with a market capitalization of $542.9B. Revenue grew 6.0% year-over-year and the company generated $19.7B in free cash flow. This page tracks JNJ's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 138.1K employees · IPO Jan 2, 1943

Valuation

Valuation & price

$226.71 · as of May 17, 2026 · -11.0% vs 52w high

20.5

P/E ratio

Latest-FY diluted EPS

6.66

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$255$205$155Jul 25Dec 25Jun 26Jul 7, 25$155.27Jul 9, 25$156.28Jul 11, 25$156.90Jul 15, 25$155.17Jul 17, 25$162.98Jul 21, 25$164.36Jul 23, 25$169.10Jul 25, 25$168.30Jul 29, 25$168.11Jul 31, 25$164.74Aug 4, 25$171.04Aug 6, 25$170.59Aug 8, 25$173.33Aug 12, 25$172.78Aug 14, 25$174.72Aug 18, 25$176.25Aug 20, 25$178.84Aug 22, 25$179.29Aug 26, 25$176.49Aug 28, 25$175.45Sep 3, 25$178.00Sep 5, 25$178.43Sep 9, 25$176.96Sep 11, 25$178.50Sep 15, 25$177.40Sep 17, 25$177.20Sep 19, 25$176.19Sep 23, 25$176.58Sep 25, 25$177.73Sep 29, 25$181.62Oct 1, 25$186.05Oct 3, 25$188.64Oct 7, 25$188.89Oct 9, 25$191.08Oct 13, 25$190.90Oct 15, 25$191.17Oct 17, 25$193.22Oct 21, 25$191.88Oct 23, 25$192.47Oct 27, 25$190.30Oct 30, 25$189.05Nov 3, 25$186.26Nov 5, 25$186.00Nov 7, 25$186.57Nov 11, 25$193.83Nov 13, 25$195.25Nov 17, 25$199.58Nov 19, 25$202.51Nov 21, 25$203.90Nov 25, 25$206.67Nov 28, 25$206.92Dec 2, 25$205.42Dec 4, 25$202.48Dec 8, 25$201.62Dec 10, 25$206.54Dec 12, 25$211.58Dec 16, 25$209.30Dec 18, 25$208.31Dec 22, 25$207.32Dec 24, 25$207.78Dec 29, 25$207.56Jan 2, 26$207.35Jan 6, 26$204.79Jan 8, 26$205.75Jan 12, 26$209.72Jan 14, 26$218.55Jan 16, 26$218.66Jan 21, 26$218.01Jan 23, 26$220.14Jan 27, 26$224.44Jan 29, 26$227.29Feb 2, 26$230.75Feb 4, 26$234.47Feb 6, 26$239.99Feb 10, 26$238.35Feb 12, 26$244.55Feb 17, 26$243.33Feb 19, 26$246.91Feb 23, 26$245.84Feb 25, 26$245.17Mar 2, 26$248.56Mar 4, 26$245.30Mar 6, 26$240.40Mar 10, 26$243.71Mar 12, 26$242.04Mar 16, 26$243.19Mar 18, 26$237.28Mar 20, 26$235.37Mar 24, 26$235.27Mar 26, 26$239.26Mar 30, 26$242.49Apr 1, 26$244.12Apr 6, 26$240.97Apr 8, 26$241.30Apr 10, 26$238.46Apr 14, 26$240.10Apr 16, 26$234.54Apr 20, 26$230.69Apr 22, 26$226.10Apr 24, 26$227.50Apr 28, 26$227.79May 1, 26$227.19May 5, 26$225.59May 7, 26$222.51May 11, 26$221.43May 13, 26$230.42May 15, 26$226.71May 19, 26$230.00May 21, 26$231.73May 26, 26$230.18May 28, 26$230.80Jun 1, 26$223.51Jun 3, 26$223.24Jun 5, 26$232.77Jun 9, 26$237.00Jun 11, 26$238.33Jun 15, 26$235.66Jun 17, 26$234.20Jun 22, 26$231.29Jun 26, 26$254.66
$155.1752-week range$254.66
Loading valuation history…

Fundamentals

Key fundamentals

$542.9B

Market cap

6.0%

Revenue growth (YoY)

72.8%

Gross margin

$19.7B

Free cash flow (USD)

$27.8B

Net debt

0.9%

Share dilution

1/3

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$71.9BFY 2017$76.5BFY 2018$81.6BFY 2019$82.1BFY 2021$82.6BFY 2022$78.7BFY 2023$80.0BFY 2024$88.8BFY 2025$94.2B
$71.9B$94.2B

Free cash flow by year

2016 → 2025

FY 2016$15.5BFY 2017$17.8BFY 2018$18.5BFY 2019$19.9BFY 2021$20.2BFY 2022$19.8BFY 2023$17.2BFY 2024$19.8BFY 2025$19.7B
$15.5B$19.7B

Gross margin by year

2021 → 2025

FY 202165.6%FY 202270.3%FY 202369.3%FY 202469.1%FY 202572.8%
65.6%72.8%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

1

Insider sells · 90 days

Earnings

Last report: 10-Q filed Apr 22, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $2.4MWengel Kathryn E · EVP, Chief TO and Risk Officer · $2.4MJun 12, 2026Filing
  • 8-K eventAnnual Meeting ResultsApr 28, 2026Filing
  • Quarterly report10-Q FiledApr 22, 2026Filing
  • 8-K eventEarnings ReleaseApr 14, 2026Filing

Questions

Frequently asked questions

What is Johnson & Johnson's market cap?

Johnson & Johnson (JNJ) has a market capitalization of $542.9B.

What is JNJ's P/E ratio?

JNJ trades at a price-to-earnings ratio of 20.5, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is JNJ's price-to-book (P/B) ratio?

JNJ trades at 6.66 times book value per share.

Are insiders buying JNJ stock?

SEC Form 4 filings show no open-market insider buys at Johnson & Johnson in the last 90 days (1 sell).

Same arena

Related companies in Drug Manufacturers - General

ABBV

AbbVie Inc.

$382B

MRK

Merck & Co., Inc.

$293.4B

AZN

AstraZeneca PLC

$288.5B

NVS

Novartis AG

$287.1B

AMGN

Amgen Inc.

$180.9B

GILD

Gilead Sciences, Inc.

$167.4B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.